U.S. Wireless Telecom Stock News

In March 2026, Domino's Pizza, Inc. disclosed that shareholder proponents John Chevedden and The Accountability Board had submitted governance proposals, on majority-vote consequences for directors and on requiring an independent board chair, for consideration at the April 21, 2026 annual meeting, which the company has urged shareholders to vote against. These contested governance proposals emerge just as Warren Buffett’s nearly 10% ownership stake has intensified attention on how Domino’s...

Klarna and eBay previously expanded Klarna’s embedded resell integration to six additional markets, enabling Klarna app users to list eligible purchases on eBay with auto-filled images and details, while eBay also reported a fourth-quarter earnings beat, an acquisition worth about US$1.20 billion, and a new US$2.00 billion share repurchase plan. This combination of deeper payments-linked resale capabilities and capital allocation moves highlights how eBay is tying circular commerce trends to...

In recent days, Ares Management’s shares recovered after earlier private-credit-driven selling, as investors moved to qualify for upcoming dividend payments and reacted to sector sentiment shifts. Beyond the short-term trading, management’s emphasis on healthy portfolio metrics, including zero percent non-accruals in its large non-traded BDC, offers a contrasting picture to market concerns about private credit risk. We’ll now examine how this rebound, shaped by dividend timing and private...

Terex stock moves after recent performance shift Terex (TEX) has drawn fresh attention after a one-month return of about a 14% decline, in contrast with a roughly 12% gain over the past 3 months and a 52% total return over the past year. See our latest analysis for Terex. Recent trading has cooled, with a 7 day share price return of a 3.49% decline and a 30 day share price return of a 14.23% decline. However, the 1 year total shareholder return of 51.95% shows longer term holders are still...

CDW hits 52-week low after brief earnings-driven rebound CDW (CDW) has slipped to a new 52-week low, extending a difficult run for the stock after a short-lived bounce that followed quarterly earnings beating forecasts on both earnings and revenue. See our latest analysis for CDW. The latest drop to a 52-week low comes after a short-lived post earnings jump in early February. The 90-day share price return of 18.49% and 1-year total shareholder return of 29.56% now point to fading momentum...

Blue Owl Capital (NYSE:OWL) has come under scrutiny after its actions led to the collapse of UK mortgage lender Century Capital Partners following the discovery of financial irregularities. The lender has entered administration, and the situation is drawing wider attention to risk oversight and transparency in the private credit market. Regulators, counterparties, and investors are assessing what the episode signals about controls and monitoring practices across the sector. For investors...

If you are wondering whether Visteon at around US$90 offers genuine value or only appears cheap on the surface, this breakdown will help you frame that question clearly. The stock is around US$90.06 after a 0.7% fall over 7 days, a 14.2% drop over 30 days and a 7.0% decline year to date. The 1 year return is 12.7%, and the 3 and 5 year returns are 42.3% and 25.8% lower respectively. These mixed returns have put the focus back on what investors are paying for Visteon's future. Recent coverage...

Graphic Packaging Holding (GPK) is back on investor radar after appointing veteran automotive and industrial executive Jeffrey Stafeil to its Board of Directors, alongside a fresh amendment to its credit agreement. See our latest analysis for Graphic Packaging Holding. Despite the board refresh and credit agreement amendment, the 30 day share price return of 20.29% and the year to date share price return decline of 34.65%, alongside a 61.10% 1 year total shareholder return decline, point to...

Earlier this month, Blood Cancer United and Tempus AI announced a collaboration to build a comprehensive, patient-centered real-world registry for pediatric acute myeloid leukemia, using Tempus’ olivia app and Lens analytics platform to unify data, support families, and inform research. This partnership, alongside new research showing Tempus’ advanced genomic profiling can uncover treatment-relevant findings missed by standard tests, highlights how the company’s AI and data tools are...

CVS Health (NYSE:CVS) has launched Health100, an AI powered digital health engagement platform. The company is partnering with Google Cloud to support Health100 with advanced AI tools and health data interoperability. The platform is designed as an open, omni channel system that connects health data, services, and real time care engagement for consumers. CVS Health sits at the intersection of retail pharmacies, insurance, and care delivery, so any move it makes in digital health can matter...

Herc Holdings recently reported fourth-quarter 2025 revenue of US$1.21 billion, up 27.1% year on year but below analyst expectations, and issued full-year revenue and EBITDA guidance that also came in weaker than the market had anticipated. The company is emphasizing integration of its June 2025 purchase of H&E, the largest acquisition in its industry, as a key lever for long-term value creation despite the softer outlook. We’ll now examine how Herc’s weaker-than-expected full-year guidance,...

Regal Rexnord recently updated investors on its CEO succession process, stating that current CEO Louis Pinkham will remain in place until June 30, 2026, or until a successor is appointed, while the board’s search committee advances its identification of several highly qualified candidates. This extended timeline and structured search process underscore the board’s emphasis on leadership continuity, an important consideration for a company executing complex integration, automation, and...

Tencent Music Entertainment Group recently reported fourth-quarter and full-year 2025 results showing higher revenue and net income year-on-year, and announced an ordinary annual cash dividend of US$0.12 per share (US$0.24 per ADS), totaling about US$368.00 million, payable to shareholders of record as of April 2, 2026. The combination of stronger earnings and a defined cash return to shareholders through the declared dividend adds fresh context to Tencent Music’s existing investment...

MPLX (NYSE:MPLX) is increasing investment in natural gas and NGL infrastructure projects. The company is emphasizing fee-based, long term contracts that are less sensitive to oil price moves. Recent geopolitical tensions affecting oil markets have not directly affected MPLX's reported business performance. For investors watching MPLX at a share price of $58.1, the focus has shifted toward how its assets in natural gas and NGLs support the current business mix. The stock has returned 7.9%...

Watts Water Technologies recently reported strong fourth-quarter and full-year 2025 results, highlighted by record financial metrics, contributions from the Haws, Superior Boiler and Saudi Cast acquisitions, and a quarterly dividend of US$0.52 per share paid on March 13, 2026. Alongside these results, management’s expectation of 8–12% sales expansion and operating margin improvement for 2026, combined with an analyst upgrade, has sharpened attention on how acquisitions and higher-margin...

Ashland recently reported past growth in its Life Sciences revenue and adjusted EBITDA, narrowed its FY2026 adjusted EBITDA outlook to US$400 million–US$420 million, and outlined roughly US$30 million of expected FY2026 savings from a broader US$90 million manufacturing optimization program. Despite headwinds from a facility outage and asbestos litigation reserves, Ashland emphasized a strong balance sheet and plans for double-digit-plus adjusted EPS growth, underscoring how cost initiatives...

Bristol-Myers Squibb's Opdualag has been introduced as a first-line immunotherapy option for advanced melanoma in NHS Scotland. The treatment combines nivolumab and relatlimab as a dual-checkpoint immunotherapy approach. This decision expands patient access to a new immunotherapy option within a major public health system. For investors tracking NYSE:BMY, this development adds a fresh real world milestone to a story that recently centered on pipeline names like mezigdomide and Sotyktu. The...

Strategy (NasdaqGS:MSTR) acquired 22,337 BTC in a single week, its largest Bitcoin purchase since January. The company now holds more than 761,000 BTC, remaining the largest public corporate holder of Bitcoin. The transaction was funded mainly through issuances of STRC preferred shares and common equity. Strategy is targeting 1 million BTC holdings by the end of 2026 as part of its Bitcoin focused corporate strategy. Strategy, formerly known as MicroStrategy, has gradually shifted from a...

Wondering if Spire's current share price still offers value, or if most of the opportunity is already priced in? This article breaks down what the numbers can and cannot tell you about that question. Spire recently closed at US$92.11, with returns of 0.3% over the past week and month, 10.7% year to date, and 25.7% over the last year, alongside 49.7% over three years and 57.5% over five years. Recent coverage around Spire has focused on its position within the gas utilities space and how...

In early 2026, U.S. Physical Therapy introduced new executive incentive and bonus plans, including restricted stock units and annual bonuses linked to Adjusted EBITDA performance targets, while analysts commented on growth opportunities, Medicare rate trends, and acquisition activity. The shift toward performance-tied equity awards and bonuses offers a clearer view of how management incentives may influence capital allocation, growth priorities, and risk-taking across the business. We will...

Intuit (NasdaqGS:INTU) executives and the company’s founder have voluntarily terminated all existing 10b5-1 pre-scheduled stock sale plans. The company plans to accelerate use of its remaining $3.5b share repurchase authorization in the second half of fiscal 2026. Leadership is presenting these moves as a clear signal of confidence in Intuit’s current valuation and long term outlook. For investors tracking Intuit at a share price of $452.31, this is being framed as a strong show of...

ADMA Biologics recently reported strong 2025 performance driven by higher demand for its immune globulin therapy ASCENIV, alongside improved payer coverage and confidence in long-term plasma supply that together provide clearer visibility into 2026 revenue acceleration. The FDA’s approval of a yield-enhancement manufacturing process is particularly important, as it is expected to lift production efficiency while supporting higher margins and longer-term capital return efforts. Now we’ll...

NCCN updated its 2026 bladder cancer guidelines to include ANKTIVA plus BCG for BCG-unresponsive non-muscle invasive bladder cancer with papillary-only disease. This recommendation extends beyond the current FDA-approved labeling, which focuses on carcinoma in situ. The change highlights a potential off-label use that could influence clinical adoption and reimbursement decisions. For investors watching ImmunityBio (NasdaqGS:IBRX), this guideline shift lands after a period of intense focus...

Fortune Brands Innovations (FBIN) is under pressure after Q4 earnings and 2026 guidance came in below expectations, followed by analyst downgrades and a 10 day, 21% share price slide. See our latest analysis for Fortune Brands Innovations. The recent Q4 earnings miss, softer 2026 guidance and leadership shake up, including interim CEO and CFO appointments and the addition of activist-backed director Ed Garden, have coincided with a fading trend in the shares, with a 30 day share price return...